Free Trial

Eloxx Pharmaceuticals (ELOX) SEC Filings & 10K Form

Eloxx Pharmaceuticals logo
$0.0001 +0.00 (+∞)
As of 08/28/2025 09:30 AM Eastern

Recent Eloxx Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/12/2025
4:22 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
9:00 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form SEC STAFF ACTION
01/28/2025
4:35 PM
Androski Lindsay (Reporting)
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:36 PM
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Rubin Steven D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:37 PM
Aggarwal Sumit (Reporting)
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:34 PM
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Walts Alan Edmund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ELOX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners